Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient

Effie W. Petersdorf(Fred Hutch Cancer Center), Theodore A. Gooley(Fred Hutch Cancer Center), Claudio Anasetti(Fred Hutch Cancer Center), Paul J. Martin(Fred Hutch Cancer Center), Anajane G. Smith(Fred Hutch Cancer Center), Eric Mickelson(Fred Hutch Cancer Center), Ann E. Woolfrey(Fred Hutch Cancer Center), John A. Hansen(Fred Hutch Cancer Center)
Blood
November 15, 1998
Cited by 477

Abstract

In unrelated marrow transplantation, the benefit of matching class II HLA-DRB1 and DQB1 alleles of the donor and recipient is well documented. Little is known about the clinical relevance of matching for class I HLA-A, B, and C alleles. We used DNA-amplification methods to identify the HLA-A, B, and C alleles of 300 patients and their donors. The incidence of graft failure was correlated with multiple class I mismatching in the donor. The risk of grades III-IV acute graft-versus-host disease was highest with class II mismatching in the recipient. Mismatching for a single class I or class II allele had no effect on survival, but mortality was increased by mismatching for more than one class I allele and by simultaneous mismatching for class I and class II alleles. We conclude that matching HLA class I and class II alleles of the donor and recipient can improve outcome after unrelated marrow transplantation.


Related Papers